Stock listing

Dusseldorf:MYE0 MaxCyte, Inc. Aktie

German listing (Dusseldorf) of MaxCyte, Inc. · home listing NASDAQ:MXCT

Follow MaxCyte, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:MXCT

$1.37 USD +0.12 (+9.6%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MXCT

Past year -16.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.27 – $1.42 USDNov 20, 2026
Volume
1.11M sharesNov 20, 2026
Market cap
$141.5M USDAt the close on Nov 20, 2026 · price × 103.3M shares outstanding
52-week range
$0.643 – $1.80 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.31M USDMedian day 542,900 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
MaxCyte, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MXCT · Home$1.37 USD+0.12 (+9.6%)1,108,161$1.29$1.42$1.27$1.25Close on Nov 20, 2026
Frankfurt:MYE0€1.13 EUR-0.03 (-2.6%)—€1.13€1.13€1.13€1.16Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MXCT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.37+0.12+9.6%$1.29$1.42$1.271,108,161
$1.25+0.08+6.8%$1.17$1.26$1.135968,878
$1.17-0.01-0.8%$1.19$1.255$1.161,259,643
$1.18-0.01-0.8%$1.17$1.279$1.1551,959,184
$1.190.000.0%$1.16$1.20$1.121,247,563
$1.19+0.09+8.2%$1.11$1.22$1.022,063,261
$1.10-0.03-2.7%$1.12$1.205$1.102,122,752
$1.13-0.17-13.1%$1.40$1.42$1.084,482,497
$1.30+0.04+3.2%$1.25$1.349$1.251,599,619
$1.26-0.05-3.8%$1.31$1.36$1.24876,113
$1.31-0.08-5.8%$1.39$1.421$1.29873,628
$1.39-0.07-4.8%$1.47$1.48$1.36855,958
$1.46+0.01+0.7%$1.51$1.51$1.3651,031,419
$1.45-0.14-8.8%$1.59$1.70$1.431,283,635
$1.59-0.14-8.1%$1.71$1.72$1.505963,558
$1.73+0.02+1.2%$1.71$1.76$1.6231,138,996
$1.71+0.17+11.0%$1.54$1.73$1.5021,706,103
$1.54+0.03+2.0%$1.51$1.64$1.511,577,609
$1.51+0.11+7.9%$1.39$1.53$1.3651,128,680
$1.40-0.03-2.1%$1.43$1.43$1.35757,400
$1.43-0.04-2.7%$1.44$1.51$1.431,018,800
$1.47+0.04+2.8%$1.42$1.53$1.4051,423,100
$1.43+0.13+10.0%$1.29$1.457$1.291,388,100
$1.300.000.0%$1.30$1.31$1.27986,400
$1.300.000.0%$1.32$1.32$1.281,009,500
$1.30+0.05+4.0%$1.27$1.31$1.2553,792,300
$1.25+0.286+29.7%$1.225$1.33$1.19512,670,100
$0.964-0.031-3.1%$0.981$1.01$0.936327,900
$0.995-0.015-1.5%$1.01$1.01$0.972150,000
$1.01-0.01-1.0%$1.02$1.03$0.99240,000
$1.02-0.02-1.9%$1.04$1.04$0.964476,800
$1.04-0.05-4.6%$1.07$1.08$1.04311,900
$1.09+0.01+0.9%$1.09$1.105$1.05333,100
$1.08+0.01+0.9%$1.08$1.10$1.06194,900
$1.07-0.02-1.8%$1.11$1.11$1.07228,100
$1.09-0.03-2.7%$1.12$1.16$1.08397,100
$1.12-0.06-5.1%$1.19$1.20$1.12346,500
$1.18+0.02+1.7%$1.18$1.23$1.16542,900
$1.16-0.01-0.9%$1.16$1.17$1.14284,700
$1.17-0.02-1.7%$1.20$1.20$1.16415,900
$1.190.000.0%$1.19$1.21$1.17231,700
$1.19-0.05-4.0%$1.24$1.24$1.19251,700
$1.24+0.02+1.6%$1.22$1.25$1.20259,700
$1.22+0.03+2.5%$1.19$1.24$1.18471,800
$1.19-0.005-0.4%$1.19$1.21$1.16485,200
$1.195+0.015+1.3%$1.21$1.23$1.19257,600
$1.18-0.01-0.8%$1.20$1.23$1.171299,400
$1.19+0.015+1.3%$1.18$1.20$1.171272,100
$1.175+0.015+1.3%$1.19$1.19$1.13517,700
$1.16-0.03-2.5%$1.20$1.21$1.16331,400
$1.19-0.03-2.5%$1.22$1.23$1.18300,500
$1.22-0.055-4.3%$1.29$1.29$1.22394,000
$1.275-0.005-0.4%$1.29$1.29$1.25432,900
$1.28+0.02+1.6%$1.25$1.30$1.25333,500
$1.26-0.01-0.8%$1.27$1.27$1.22425,900
$1.27+0.03+2.4%$1.24$1.305$1.22502,300
$1.24-0.05-3.9%$1.26$1.28$1.215678,900
$1.29+0.07+5.7%$1.19$1.315$1.19777,300
$1.22-0.06-4.7%$1.30$1.30$1.21563,100
$1.28-0.03-2.3%$1.31$1.325$1.28360,000
$1.31-0.04-3.0%$1.35$1.35$1.31291,900
$1.35-0.04-2.9%$1.38$1.39$1.34310,488
$1.39+0.01+0.7%$1.36$1.40$1.35620,491
$1.380.000.0%$1.40$1.40$1.355435,800
$1.38-0.01-0.7%$1.39$1.405$1.36611,800
Ticker
Dusseldorf:MYE0
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

All MaxCyte, Inc. news

MaxCyte, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
17 in the last 12 months · 96 in all · newest Nov 10, 2026 · oldest 2021
Calls
22 calls with a replay · 22 with a transcript · latest Nov 10, 2026
Decks
18 decks · latest Nov 10, 2026

Where MaxCyte, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MXCT · Home listingNASDAQUnited StatesUSD
LS Exchange:A2AGVELS ExchangeGermanyEUR
BOATS:MXCTBOATSUnited StatesUSD
Lang & Schwarz:A2AGVELang & SchwarzGermanyEUR
gettex:MYE0gettexGermanyEUR
Tradegate:MYE0TradegateGermanyEUR
Dusseldorf:MYE0 · This pageDusseldorfGermanyEUR
Frankfurt:MYE0FrankfurtGermanyEUR
Munich:MYE0MunichGermanyEUR
Stuttgart:MYE0StuttgartGermanyEUR

Valuation

EV/sales 1.7× against a median of 6.0×: 4th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$57.06M USD
P/E
Loss
EV/sales
1.7×
EV/EBITDA
Negative EBITDA
Price/book
0.9×
Gross margin
81.0%
Operating margin
−98.0%
Net margin
−81.4%
Debt to equity
0.1×
Beta vs S&P 500
0.93

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
MaxCyte, Inc. · NASDAQ:MXCTUS$141.5MUS$57.06Mn/a1.7×n/a0.9×−81.4%0.1×0.93
Boditech Med, Inc. · KRX:206640US$152.9MUS$121.7M7.9×0.9×4.4×0.8×14.8%0.0×n/a
Genovis AB · OMXSTO:GENOUS$150.1MUS$142.7M74.9×10.8×41.7×5.0×15.1%0.3×n/a
Genomictree, Inc. · KRX:228760US$148.6MUS$89.43Mn/a40.6×n/a1.6×−306.4%0.0×n/a
Anbio Biotechnology · NASDAQ:NNNNUS$145.7MUS$133.8M22.8×15.5×n/a4.8×74.1%0.0×0.56
Shanghai Rightongene Biotechnology Co. Ltd. Class A · SSE:688217US$139.0MUS$102.4Mn/a4.6×n/a1.1×−43.9%0.0×n/a
EKF Diagnostics Holdings plc · LSE:EKFUS$134.4MUS$115.4M48.4×1.7×7.1×1.5×4.1%0.0×n/a
Bioventix PLC · LSE:BVXPUS$133.3MUS$126.3M13.4×7.4×9.7×9.2×57.8%0.0×n/a
Curiosis, Inc. · KRX:494120US$131.9MUS$118.3Mn/a18.7×n/a7.1×−93.3%0.0×n/a
Bioneer Corporation · KRX:064550US$128.3MUS$107.8Mn/a0.4×10.0×0.8×−1.9%0.3×n/a
Fine Foods & Pharmaceuticals N.T.M. SpA · MIL:FFUS$123.5MUS$174.6M11.1×0.6×4.6×0.8×4.0%0.6×n/a
Median of the othersUS$136.7MUS$120.0M18.1×6.0×8.4×1.6×4.0%0.0×0.56

Forecasts

5 strong buy · 1 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
4.11 USD · Analysts' mean
EPS, year to Dec 2026
-0.27 · 4 analysts
Revenue, year to Dec 2026
34.55M · 2 analysts

Team and board

Officers

OfficerRole
Maher MasoudPresident and Chief Executive Officer
Parmeet AhujaChief Financial Officer
David DeuchlerInvestor Relations
Ana-Paula Martins FernandesSenior Vice President, Global Sales
Jill MayerSenior Vice President of Human Resources
Jay GelfmanChief Operations Officer
Sidharth KapileshwarChief Corporate Development Officer

Board

DirectorRole
Richard DouglasNon-Executive Chairman
Cynthia CollinsNon-Executive Director
John JohnstonNon-Executive Director
Maher MasoudPresident and Chief Executive Officer
Patrick BalthropNon-Executive Director
Rekha HemrajaniNon-Executive Director
Stan ErckNon-Executive Director
Will BrookeNon-Executive Director
Yasir Al-WakeelNon-Executive Director

Events

Calls

CallWhenStatus
MaxCyte (NASDAQ:MXCT) Q3 2026 Earnings CallTue, Nov 10, 2026 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q2 2026 Earnings CallWed, Aug 12, 2026 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q1 2026 Earnings CallTue, May 12, 2026 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q4 2025 Earnings CallTue, Mar 24, 2026 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q3 2025 Earnings CallWed, Nov 12, 2025 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q2 2025 Earnings CallWed, Aug 06, 2025 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q1 2025 Earnings CallWed, May 07, 2025 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q4 2024 Earnings CallTue, Mar 11, 2025 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q3 2024 Earnings CallWed, Nov 06, 2024 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q2 2024 Earnings CallTue, Aug 06, 2024 · 4:30 PM ETReplay
All 22 calls
CallWhenStatus
MaxCyte (NASDAQ:MXCT) Q1 2024 Earnings CallTue, May 07, 2024 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q4 2023 Earnings CallTue, Mar 12, 2024 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q3 2023 Earnings CallWed, Oct 04, 2023 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q2 2023 Earnings CallWed, Aug 09, 2023 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q1 2023 Earnings CallWed, May 10, 2023 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q4 2022 Earnings CallWed, Mar 15, 2023 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q3 2022 Earnings CallWed, Nov 09, 2022 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q2 2022 Earnings CallWed, Aug 10, 2022 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q1 2022 Earnings CallMon, May 09, 2022 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q4 2021 Earnings CallTue, Mar 22, 2022 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q3 2021 Earnings CallWed, Nov 10, 2021 · 4:30 PM ETReplay
MaxCyte (NASDAQ:MXCT) Q2 2021 Earnings CallMon, Sep 13, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 10, 2026 · Before open−13.1%
Q2 2026Aug 12, 2026 · After close+9.4%
Q1 2026May 13, 2026+32.6%
Q4 2025Mar 24, 2026 · After close−6.8%
Q3 2025Nov 12, 2025 · After close−4.4%
Q2 2025Aug 6, 2025 · After close−29.9%
Q1 2025May 7, 2025 · After close−11.3%
Q4 2024Mar 11, 2025−7.0%
Q3 2024Nov 6, 2024 · After close−10.8%
Q2 2024Aug 6, 2024 · After close−8.3%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · After close+18.1%
Q4 2023Mar 12, 2024 · After close+4.5%
Q3 2023Nov 8, 2023 · After close−3.3%
Q2 2023Aug 9, 2023 · After close−10.4%
Q1 2023May 10, 2023 · After close−19.8%
Q4 2022Mar 15, 2023 · After close+6.4%
Q3 2022Nov 9, 2022 · After close+15.7%
Q2 2022Aug 10, 2022 · After close+1.6%
Q1 2022May 9, 2022 · After close−0.6%
Q4 2021Mar 22, 2022 · After close+3.9%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck29 slidesNov 10, 2026
Merger or Acquisition (November 2026)Merger or acquisition14 slidesNov 10, 2026
Investor Presentation (August 2026)Investor deck29 slidesAug 12, 2026
Q2 2026 Earnings PresentationEarnings10 slidesAug 12, 2026
Investor Presentation (May 2026)Investor deck27 slidesMay 12, 2026
Investor Presentation (March 2026)Investor deck27 slidesMar 24, 2026
Investor Presentation (November 2025)Investor deck27 slidesNov 12, 2025
Investor Presentation (August 2025)Investor deck27 slidesAug 6, 2025
Q2 2025 Earnings PresentationEarnings38 slidesAug 6, 2025
Investor Presentation (May 2025)Investor deck26 slidesMay 7, 2025
All 18 decks
DeckKindSlidesDate
Investor Presentation (March 2025)Investor deck26 slidesMar 11, 2025
Investor Presentation (November 2024)Investor deck20 slidesNov 6, 2024
Investor Presentation (August 2024)Investor deck19 slidesAug 6, 2024
Investor Presentation (May 2024)Investor deck21 slidesMay 7, 2024
Corporate Update (January 2021)Corporate update17 slidesJanuary 2021
Investor Presentation (January 2021)Investor deck16 slidesJanuary 2021
H1 2020 Earnings PresentationEarnings24 slidesSeptember 2020
Technical Presentation (2007)Technical26 slides2007

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue33.0M38.6M41.3M44.3M33.9M26.2M21.6M16.7M14.0M12.3M
Cost of revenue6.22M7.10M4.74M5.10M3.65M2.77M2.50M1.84M1.45M1.31M
Gross profit26.8M31.5M36.5M39.2M30.2M23.4M19.1M14.8M12.5M11.0M
Research and development20.8M22.2M23.8M19.5M15.4M17.7M17.6M11.2M11.3M4.70M
Selling, general and administrative28.1M29.7M30.1M25.8M18.7M7.37M5.56M5.28M4.52M4.20M
Operating income-51.9M-51.2M-48.3M-27.4M-18.2M-11.1M-12.4M-8.42M-9.29M-2.72M
Depreciation and amortization4.34M4.32M4.17M2.70M1.42M1.05M613.5K344.0K142.9K105.7K
EBITDA-47.6M-46.9M-44.1M-24.7M-16.8M-10.0M-11.8M-8.08M-9.15M-2.62M
Interest expense126.9K5.40K21.7K51.9K614.6K625.3K637.8K
Income before tax-44.6M-41.1M-37.9M-23.6M-19.1M-11.8M-12.9M-8.87M-9.92M-3.35M
Income tax4.00M-3.79M000170.3K653.5K
Net income-44.6M-41.1M-37.9M-23.6M-19.1M-11.8M-12.9M-8.87M-9.92M-3.35M
Earnings per share, basic-0.42-0.39-0.37-0.23-0.21-0.17-0.23-0.17-0.20-0.10
Earnings per share, diluted-0.42-0.39-0.37-0.23-0.21-0.17-0.23

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents20.1M27.9M46.5M11.1M47.8M18.8M15.2M11.2M25.3M11.7M
Short-term investments83.0M126.6M121.8M216.3M207.3M16.0M1.50M3.19M
Receivables3.50M4.68M5.78M11.2M6.88M5.17M3.24M4.90M3.20M2.41M
Inventory7.55M8.91M12.2M8.58M5.20M4.32M3.70M2.24M1.35M1.33M
Current assets118.4M171.7M190.2M252.3M270.4M45.3M24.5M22.4M30.6M15.8M
Property, plant and equipment17.5M19.7M23.5M23.7M7.68M4.55M5.53M1.82M847.6K
Total assets202.5M239.5M268.3M286.7M284.1M51.8M30.0M24.3M31.4M16.1M
Accounts payable1.40M1.36M743.0K292.0K1.82M890.2K2.09M4.12M4.33M3.17M
Current liabilities14.3M15.8M17.9M15.4M15.6M11.6M9.34M6.57M7.24M5.65M
Long-term debt4.92M4.90M5.06M4.18M
Total debt17.9M18.0M18.7M16.1M5.68M6.97M7.21M5.06M5.03M5.01M
Total liabilities31.0M33.2M36.1M32.7M21.2M18.6M16.4M12.0M11.8M11.0M
Shareholders' equity171.5M206.3M232.2M254.0M262.9M33.2M13.6M12.3M19.6M5.08M
Shares outstanding106.8M105.7M104.0M102.4M101.2M77.4M101.5M51.2M48.6M33.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-34.4M-27.6M-21.7M-14.8M-10.7M-8.78M-8.80M-10.5M-9.68M-2.33M
Capital spending-1.77M-1.65M-3.70M-18.5M-3.83M-2.07M-1.27M-709.7K-609.7K-218.8K
Free cash flow-36.2M-29.3M-25.4M-33.3M-14.5M-10.9M-10.1M-11.2M-10.3M-2.55M
Cash from investing25.9M6.93M55.0M-24.8M-195.0M-16.6M454.5K-3.83M-609.7K-218.8K
Cash from financing656.0K2.06M2.14M2.89M234.7M28.9M12.3M226.8K23.9M11.9M
Share buybacks459.0K269.0K2.89M239.7M
Change in cash-7.82M-18.6M35.4M-36.7M29.0M3.54M3.96M-14.1M13.6M9.32M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 18, 2026Insider tradeSEC
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
8-K · Current reportNov 10, 2026ResultsSEC
SCHEDULE 13D · Big-stake noticeNov 2, 2026Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeOct 15, 2026Big-stake noticeSEC
8-K · Current reportOct 14, 2026ResultsSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportAug 12, 2026ResultsSEC
SCHEDULE 13D · Big-stake noticeAug 4, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 29, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
8-K · Current reportJun 17, 2026Meeting outcomeSEC
8-K · Current reportJun 16, 2026Current reportSEC
SCHEDULE 13D · Big-stake noticeMay 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
8-K · Current reportMay 12, 2026ResultsSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
S-8 · Registration statement for employee plansApr 15, 2026Offer documentSEC
4 · Change in ownershipApr 10, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 10, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 10, 2026Big-stake noticeSEC
4 · Change in ownershipMar 31, 2026Insider tradeSEC
8-K · Current reportMar 27, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
10-K · Annual reportMar 25, 2026Annual reportSEC
8-K · Current reportMar 24, 2026ResultsSEC
8-K · Current reportMar 20, 2026Current reportSEC
4 · Change in ownershipMar 19, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 5, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 21, 2026Big-stake noticeSEC
8-K · Current reportJan 12, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 12, 2025ResultsSEC
8-K · Current reportNov 5, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 4, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 3, 2025Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeOct 24, 2025Big-stake noticeSEC
8-K · Current reportSep 22, 2025Current reportSEC
4 · Change in ownershipAug 27, 2025Insider tradeSEC
S-8 · Registration statement for employee plansAug 26, 2025Offer documentSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
8-K · Current reportAug 11, 2025Management or board changeSEC
10-Q · Quarterly reportAug 6, 2025Quarterly reportSEC
8-K · Current reportAug 6, 2025ResultsSEC
8-K · Current reportJun 25, 2025Current reportSEC
144 · Notice of proposed saleJun 25, 2025Other filingsSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
8-K · Current reportJun 18, 2025Management or board changeSEC
DEFA14A · Additional proxy materialMay 29, 2025Meeting noticeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 7, 2025ResultsSEC
ARS · Annual report to shareholdersApr 28, 2025Annual reportSEC
DEF 14A · Proxy statementApr 28, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 15, 2025Meeting noticeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
10-K · Annual reportMar 11, 2025Annual reportSEC
8-K · Current reportMar 11, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2025Big-stake noticeSEC
8-K · Current reportJan 30, 2025Current reportSEC
4 · Change in ownershipJan 29, 2025Insider tradeSEC
4 · Change in ownershipJan 14, 2025Insider tradeSEC
8-K · Current reportJan 13, 2025ResultsSEC
4 · Change in ownershipDec 30, 2024Insider tradeSEC
8-K · Current reportDec 27, 2024Management or board changeSEC
144 · Notice of proposed saleDec 26, 2024Other filingsSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
8-K · Current reportDec 9, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 6, 2024Quarterly reportSEC
8-K · Current reportNov 6, 2024ResultsSEC
4 · Change in ownershipNov 5, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 31, 2024Big-stake noticeSEC
4 · Change in ownershipOct 30, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 21, 2024Big-stake noticeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 16, 2024Insider tradeSEC
8-K · Current reportOct 15, 2024Management or board changeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipSep 30, 2024Insider tradeSEC
144 · Notice of proposed saleSep 26, 2024Other filingsSEC
4 · Change in ownershipSep 18, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 18, 2024Insider tradeSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
144 · Notice of proposed saleSep 3, 2024Other filingsSEC
4 · Change in ownershipAug 28, 2024Insider tradeSEC
10-Q · Quarterly reportAug 6, 2024Quarterly reportSEC
8-K · Current reportAug 6, 2024ResultsSEC
4 · Change in ownershipAug 5, 2024Insider tradeSEC
4 · Change in ownershipJul 30, 2024Insider tradeSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
4 · Change in ownershipJul 1, 2024Insider tradeSEC
144 · Notice of proposed saleJun 27, 2024Other filingsSEC
4 · Change in ownershipJun 24, 2024Insider tradeSEC
144 · Notice of proposed saleJun 20, 2024Other filingsSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
8-K · Current reportJun 12, 2024Management or board changeSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC
10-Q · Quarterly reportMay 7, 2024Quarterly reportSEC
8-K · Current reportMay 7, 2024ResultsSEC
ARS · Annual report to shareholdersMay 1, 2024Annual reportSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
4 · Change in ownershipMar 28, 2024Insider tradeSEC
SC 13G · Big-stake noticeMar 25, 2024Big-stake noticeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
10-K · Annual reportMar 12, 2024Annual reportSEC
8-K · Current reportMar 12, 2024ResultsSEC
8-K · Current reportMar 5, 2024ResultsSEC
3 · Initial statement of ownershipMar 4, 2024Insider tradeSEC
4 · Change in ownershipFeb 28, 2024Insider tradeSEC
144 · Notice of proposed saleFeb 26, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 1, 2024Big-stake noticeSEC
4 · Change in ownershipJan 30, 2024Insider tradeSEC
8-K · Current reportJan 26, 2024Management or board changeSEC
SC 13G/A · Big-stake notice, amendedJan 26, 2024Big-stake noticeSEC
8-K · Current reportJan 8, 2024ResultsSEC
4 · Change in ownershipJan 4, 2024Insider tradeSEC
4 · Change in ownershipDec 28, 2023Insider tradeSEC
8-K · Current reportDec 11, 2023Management or board changeSEC
4 · Change in ownershipDec 6, 2023Insider tradeSEC
4 · Change in ownershipDec 1, 2023Insider tradeSEC
4 · Change in ownershipNov 29, 2023Insider tradeSEC
144 · Notice of proposed saleNov 29, 2023Other filingsSEC
SC 13G · Big-stake noticeNov 17, 2023Big-stake noticeSEC
4 · Change in ownershipNov 16, 2023Insider tradeSEC
144 · Notice of proposed saleNov 14, 2023Other filingsSEC
10-Q · Quarterly reportNov 8, 2023Quarterly reportSEC
8-K · Current reportNov 8, 2023ResultsSEC
8-K · Current reportOct 4, 2023ResultsSEC
4 · Change in ownershipAug 30, 2023Insider tradeSEC
10-Q · Quarterly reportAug 9, 2023Quarterly reportSEC
8-K · Current reportAug 9, 2023ResultsSEC
4 · Change in ownershipJul 28, 2023Insider tradeSEC
4 · Change in ownershipJul 12, 2023Insider tradeSEC
144 · Notice of proposed saleJul 10, 2023Other filingsSEC
4 · Change in ownershipJun 28, 2023Insider tradeSEC
144 · Notice of proposed saleJun 26, 2023Other filingsSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
8-K · Current reportJun 23, 2023Management or board changeSEC
4 · Change in ownershipJun 15, 2023Insider tradeSEC
10-Q · Quarterly reportMay 10, 2023Quarterly reportSEC
8-K · Current reportMay 10, 2023ResultsSEC
4 · Change in ownershipMay 5, 2023Insider tradeSEC
ARS · Annual report to shareholdersApr 28, 2023Annual reportSEC
DEF 14A · Proxy statementApr 28, 2023Meeting noticeSEC
4 · Change in ownershipApr 12, 2023Insider tradeSEC
4 · Change in ownershipApr 12, 2023Insider tradeSEC
4 · Change in ownershipApr 7, 2023Insider tradeSEC
4 · Change in ownershipApr 7, 2023Insider tradeSEC
4 · Change in ownershipApr 4, 2023Insider tradeSEC
4 · Change in ownershipApr 4, 2023Insider tradeSEC

This page holds 200 of 339 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from MaxCyte, Inc.’s releases · as of Nov 6, 2026

Common shares
103,250,292
Fully diluted
103,250,292

Fully diluted

LineSharesAs of
Common shares103,250,292Nov 6, 2026

Share count over time

CountShares
Nov 6, 2026103,250,292
Sep 30, 2026103,233,238

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Capricorn Fund Managers Ltd8.2M7.9%US$9.18MSep 30, 2026
Vitruvian Partners LLP5.04M4.9%US$5.65MSep 30, 2026
Vanguard5.01M4.8%US$5.61MSep 30, 2026
Liontrust Investment Partners LLP4.84M4.7%US$5.42MSep 30, 2026
Morgan Stanley3.98M3.9%US$4.46MSep 30, 2026
BlackRock3.03M2.9%US$3.39MSep 30, 2026
BNP Paribas2.85M2.8%US$3.2MSep 30, 2026
Cadian Capital Management, LP2.62M2.5%US$2.94MSep 30, 2026
Two Sigma2.43M2.3%US$2.72MSep 30, 2026
Mudita Advisors LLP2.26M2.2%US$2.53MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Renaissance Technologies2.04M2.0%US$2.28MSep 30, 2026
Peapod Lane Capital LLC1.98M1.9%US$2.22MSep 30, 2026
RBF Capital, LLC1.63M1.6%US$1.82MSep 30, 2026
Brooklands Fund Management Ltd1.56M1.5%US$1.75MSep 30, 2026
Marshall Wace, LLP1.56M1.5%US$1.75MSep 30, 2026
Nano Cap New Millennium Growth Fund L P1.5M1.5%US$1.68MSep 30, 2026
Geode Capital1.25M1.2%US$1.4MSep 30, 2026
Citadel1.15M1.1%US$1.28MSep 30, 2026
Goldman Sachs914K0.89%US$1.02MSep 30, 2026
Gsa Capital Partners LLP891K0.86%US$998KSep 30, 2026
Willis Investment Counsel863K0.84%US$966KSep 30, 2026
Millennium690K0.67%US$773KSep 30, 2026
Jane Street635K0.62%US$711KSep 30, 2026
Susquehanna569K0.55%US$637KSep 30, 2026
State Street484K0.47%US$542KSep 30, 2026
AQR Capital Management LLC453K0.44%US$507KSep 30, 2026
Arrowstreet Capital, Limited Partnership426K0.41%US$477KSep 30, 2026
Acadian Asset Management LLC416K0.40%US$461KSep 30, 2026
George Kaiser Family Foundation332K0.32%US$372KSep 30, 2026
Jacobs Levy Equity Management, Inc313K0.30%US$351KSep 30, 2026
Apollo Management Holdings, L.P.308K0.30%US$345KSep 30, 2026
HSBC274K0.27%US$324KSep 30, 2026
Northern Trust264K0.26%US$296KSep 30, 2026
Dimensional242K0.23%US$272KSep 30, 2026
Russell Investments Group, Ltd.238K0.23%US$268KSep 30, 2026
Stonepine Capital Management, LLC225K0.22%US$252KSep 30, 2026
Corient Private Wealth LP211K0.20%US$237KSep 30, 2026
Rathbones Group PLC201K0.19%US$225KSep 30, 2026
UBS189K0.18%US$211KSep 30, 2026
Diametric Capital, LP183K0.18%US$205KSep 30, 2026
Bank of America181K0.18%US$203KSep 30, 2026
CPP Investments178K0.17%US$199KSep 30, 2026
Fidelity175K0.17%US$196KSep 30, 2026
Barclays147K0.14%US$165KSep 30, 2026
Callan Family Office, LLC143K0.14%US$160KSep 30, 2026
Squarepoint Ops LLC134K0.13%US$150KSep 30, 2026
Graham Capital Management, L.P.121K0.12%US$135KSep 30, 2026
Schwab117K0.11%US$131KSep 30, 2026
Cabot Wealth Management Inc88,6230.09%US$99,258Sep 30, 2026
Quadrature Capital Ltd84,8750.08%US$95,060Sep 30, 2026

This page holds 50 of 114 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund2.74M2.7%US$3.37MJun 30, 2026
Vanguard Extended Market Index Fund1.16M1.1%US$1.43MJun 30, 2026
Vanguard Russell 2000 Index Fund519K0.50%US$627KMay 31, 2026
Fidelity Extended Market Index Fund394K0.38%US$477KMay 31, 2026
Inception Portfolio347K0.34%US$427KJun 30, 2026
Vanguard Health Care Index Fund302K0.29%US$365KMay 31, 2026
EQ/Morgan Stanley Small Cap Growth Portfolio212K0.21%US$261KJun 30, 2026
Fidelity Total Market Index Fund200K0.19%US$241KMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF165K0.16%US$202KJun 30, 2026
Fidelity Series Total Market Index Fund156K0.15%US$189KMay 31, 2026
All 45 holders
HolderSharesOf the companyValueAs of
Multi-Manager Small Cap Equity Strategies Fund144K0.14%US$174KMay 31, 2026
Schwab Total Stock Market Index Fund115K0.11%US$121KJul 31, 2026
Large-Cap Growth Portfolio110K0.11%US$135KJun 30, 2026
Goldman Sachs Absolute Return Tracker Fund109K0.11%US$135KJun 30, 2026
Invesco NASDAQ Future Gen 200 ETF94,7090.09%US$115KMay 31, 2026
Vanguard Russell 2000 Value Index Fund77,1560.07%US$93,359May 31, 2026
Diversified Equity Alpha Master Portfolio74,4090.07%US$91,523Jun 30, 2026
Fidelity Nasdaq Composite Index Fund57,2790.06%US$69,308May 31, 2026
Fidelity ZERO Total Market Index Fund56,0500.05%US$58,853Jul 31, 2026
Vitality Portfolio49,4610.05%US$34,746Mar 31, 2026
Vanguard Balanced Index Fund46,7910.05%US$57,553Jun 30, 2026
Bridge Builder Small/Mid Cap Value Fund46,4730.05%US$57,162Jun 30, 2026
NVIT Multi-Manager Small Company Fund43,4280.04%US$53,416Jun 30, 2026
Small Cap Index Fund40,9600.04%US$49,562May 31, 2026
Fidelity ZERO Extended Market Index Fund38,1850.04%US$40,094Jul 31, 2026
NVIT Small Cap Value Fund37,1600.04%US$45,707Jun 30, 2026
AVIP Fidelity Institutional AM Equity Growth Portfolio22,6450.02%US$27,853Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund22,3210.02%US$27,455Jun 30, 2026
Siit Extended Market Index Fund20,5000.02%US$24,805May 31, 2026
JNL/DFA U.S. Small Cap Fund18,5210.02%US$22,781Jun 30, 2026
Fidelity Flex Small Cap Index Fund18,1200.02%US$19,026Jul 31, 2026
AST Small-Cap Equity Portfolio12,4500.01%US$15,314Jun 30, 2026
Victory Extended Market Index Fund11,4570.01%US$12,030Jul 31, 2026
Guardian Large Cap Fundamental Growth VIP Fund7,867<0.01%US$9,676Jun 30, 2026
Vanguard Russell 3000 Index Fund7,598<0.01%US$9,194May 31, 2026
VIP Extended Market Index Portfolio6,828<0.01%US$8,398Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund5,380<0.01%US$6,617Jun 30, 2026
ProShares Russell 2000 High Income ETF4,758<0.01%US$5,757May 31, 2026
Morgan Stanley Pathway Small-Mid Cap Equity ETF3,837<0.01%US$4,643May 31, 2026
ProShares UltraPro Russell20003,760<0.01%US$4,550May 31, 2026
ProShares Ultra Russell20003,722<0.01%US$4,504May 31, 2026
Destinations Small-Mid Cap Equity Fund3,354<0.01%US$4,058May 31, 2026
VIP Total Market Index Portfolio2,235<0.01%US$2,749Jun 30, 2026
ProShares Hedge Replication ETF95<0.01%US$115May 31, 2026
ProShares Russell 2000 Dynamic Buffer ETF29<0.01%US$35May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Masoud Maher
Director, Officer: President and CEO
Buy100,000USD 1.21US$121KNov 17, 2026

Big stakes

StakeStakeSharesDateFiling
Capricorn Fund Managers Ltd7.70%8.2MJan 30, 2026Schedule 13G
Liontrust Investment Partners LLP4.90%5.08MOct 30, 2026Schedule 13D
RIVER GLOBAL INVESTORS LLP0.80%834KJul 31, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rekha Hemrajani
Other companies: LB Pharmaceuticals Inc (Director · Since at least Sep 10, 2025); BioAge Labs, Inc. (Director · Since at least Apr 17, 2024); ALX Oncology Holdings Inc. (Director · Since at least Jun 15, 2022)
Non-Executive Director · Since at least Jun 29, 2022
Cynthia Collins
Other companies: Certara, Inc. (Director · Since at least May 21, 2025); Codexis, Inc. (Director · Since at least Mar 28, 2025)
Director · Since at least Jun 18, 2025
Richard H. Douglas
Other companies: Novavax, Inc. (Director · Since at least Jun 20, 2026); Aldeyra Therapeutics, Inc. (Director · Since at least Jun 10, 2026)
Director · Since at least Dec 22, 2024
Douglas J. Swirsky
Other companies: Cellectar Biosciences, Inc. (Director · Since at least Jun 14, 2024)
CHIEF FINANCIAL OFFICER · Since at least Mar 15, 2024
Ali SoleymannezhadChief Commercial Officer · Sep 11, 2024 – Mar 18, 2025 · Past
Amanda Louise MurphyChief Financial Officer · Jul 29, 2021 – Mar 25, 2022 · Past
Ana-Paula Martins FernandesSenior Vice President, Global Sales · Since at least Nov 5, 2026
David DeuchlerInvestor Relations · Since at least Jan 12, 2026
Douglas DoerflerPresident and CEO, Director · Jul 29, 2021 – Dec 4, 2023 · Past
Jay GelfmanChief Operations Officer · Since at least Nov 5, 2026
All 23 people
PersonSeat
Jill MayerSenior Vice President of Human Resources · Since at least Nov 5, 2026
John JohnstonNon-Executive Director · Since at least Jun 22, 2026
Maher MasoudPresident and Chief Executive Officer · Since at least Jul 29, 2021
Parmeet AhujaChief Financial Officer · Since at least Mar 31, 2026
Patrick BalthropNon-Executive Director · Since at least Jun 22, 2026
Ron HoltzChief Financial Officer · Jul 29, 2021 – Mar 20, 2023 · Past
Sidharth KapileshwarChief Corporate Development Officer · Since at least Sep 23, 2026
Stan ErckNon-Executive Director · Since at least Jun 22, 2026
Stanley C ErckDirector · Since at least Jun 18, 2025
Thomas M RossEVP, GLOBAL SALES · Jul 29, 2021 – Aug 1, 2024 · Past
Will BrookeNon-Executive Director · Since at least Jun 22, 2026
William W BrookeDirector · Since at least Jun 18, 2025
Yasir Al-WakeelDirector · Since at least Jun 11, 2024

Open People

Log in to ask 6ix AI your own questions about MaxCyte, Inc.